1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII

European Journal of Medicinal Chemistry

Volumn 43, Issue 11, 2008, Pages 2618-2626

  Calderone, Vincenzo ^a   Fiamingo, Francesca Lidia ^a   Amato, Gabriella ^a   Giorgi, Irene ^a   Livi, Oreste ^a   Martelli, Alma ^a   Martinotti, Enrica ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

BK activator; BK potassium channel; Triazole carboxamide; Triazole carboxanilide

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 1,2,3 TRIAZOL (N BENZYL)CARBOXAMIDE DERIVATIVE; 1,2,3 TRIAZOLCARBOXANILIDE DERIVATIVE; AMIDE; HETEROCYCLIC COMPOUND; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; DRUG STRUCTURE; MALE; NONHUMAN; PHARMACOPHORE; PHYSICAL CHEMISTRY; RAT; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ALKYNES; AMIDES; ANILIDES; ANIMALS; AZOLES; MALE; MOLECULAR STRUCTURE; POTASSIUM CHANNELS; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 54149103072     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.02.032     Document Type: Article

References (20)

1. Calderone V. Curr. Med. Chem. 9 (2002) 1385-1395
2. Wu S.-N. Curr. Med. Chem. 10 (2003) 649-661
3. Ghatta S., Nimmagadda D., Xu X., and O'Rourke S. Pharmacol. Ther. 110 (2006) 103-116
4. Brayden J.E., and Nelson M.T. Science 256 (1992) 532-535
5. Tanaka Y., Koike K., and Toro L. J. Smooth Muscle Res. 4 & 5 (2004) 125-153
6. Biagi G., Calderone V., Giorgi I., Livi O., Scartoni V., Baragatti B., and Martinotti E. Eur. J. Med. Chem. 35 (2000) 715-720
7. Baragatti B., Biagi G., Calderone V., Giorgi I., Livi O., Martinotti E., and Scartoni V. Eur. J. Med. Chem. 35 (2000) 949-955
8. Biagi G., Calderone V., Giorgi I., Livi O., Scartoni V., Baragatti B., and Martinotti E. Farmaco 56 (2001) 841-849
9. Biagi G., Giorgi I., Livi O., Scartoni V., Barili P.L., Calderone V., and Martinotti E. Farmaco 56 (2001) 827-834
10. Olesen S.P., Munch E., Moldt P., and Drejer J. Eur. J. Pharmacol. 251 (1994) 53-59
11. Biagi G., Calderone V., Giorgi I., Livi O., Martinotti E., Martelli A., and Nardi A. Farmaco 59 (2004) 397-404
12. Calderone V., Giorgi I., Livi O., Martinotti E., Martelli A., and Nardi A. Farmaco 60 (2005) 367-375
13. Calderone V., Giorgi I., Livi O., Martinotti E., Mantuano E., Martelli A., and Nardi A. Eur. J. Med. Chem. 40 (2005) 521-528
14. Biagi G., Giorgi I., Livi O., Nardi A., Calderone V., Martelli A., Martinotti E., and LeRoy Salerni O. Eur. J. Med. Chem. 39 (2004) 491-498
15. Calderone V., Fiamingo F.L., Giorgi I., Leonardi M., Livi O., Martelli A., and Martinotti E. Eur. J. Med. Chem. 41 (2006) 761-767
16. Calderone V., Coi A., Fiamingo F.L., Giorgi I., Leonardi M., Livi O., Martelli A., and Martinotti E. Eur. J. Med. Chem. 41 (2006) 1421-1429
17. V. Calderone, F.L. Fiamingo, G. Amato, I. Giorgi, O. Livi, A. Martelli, E. Martinotti, Eur. J. Med. Chem. in press, doi:10.1016/j.ejmech.2007.06.05
18. Biagi G., Giorgi I., Livi O., Manera C., Scartoni V., Lucacchini A., and Senatore G. Farmaco 51 (1996) 601-608
19. Kreher R., and Bergman U. Tetrahedron Lett. 47 (1976) 4259-4262
20. A.K. Amegadzie, K.M. Gardinier, E.J. Hembre, P.A. Hipskind, L.N. Jungheim, B.S. Muhel, K.A. Savin, K.J. Thrasher, S.A. Boyd, PCT Int. Appl. WO2005000821, (2005).